Tirzepatide
Dual GIP/GLP-1 receptor agonist studied in metabolic research.
Description
A dual-acting peptide that targets both the GIP and GLP-1 receptors. Frequently studied in glucose regulation and weight-management research due to its influence on insulin response and satiety signaling.
Additional information
| Size | 5mg, 10mg, 30mg |
|---|
Reviews
There are no reviews yet.